CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF

Delisted

CNCR was delisted on the 27th of May, 2025.

18 hedge funds and large institutions have $10.4M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.47M
2
$814K
3
$510K
4
$474K
5
$450K
6
$358K
7
$344K
8
$268K
9
$208K
10
$207K
11
$123K
12
$82K
13
$38K
14
$28K
15
$19K
16
$10K
17
$6K
18
$2K
19
20
21
22
23